Share

Prevention and Cessation

We are working to increase funding for comprehensive tobacco control programs and access to evidence-based cessation treatment, which prevents youth initiation and supports successful quitting. Additionally, raising the minimum sale age for tobacco to 21 can prevent a deadly addiction. 

Prevention and Cessation Resources:

Tobacco use has been found to be one of the primary drivers of cancer-related health disparities because its use disproportionately impacts people based on race, ethnicity, sexual orientation, gender identity, disability status, mental health, income level, education level, and geographic location. Achieving health equity relies heavily on eliminating tobacco use. ACS CAN is pursuing fact-based tobacco control policies at the local, state and federal levels that aim to reduce disparities and improve health outcomes for everyone.

Tobacco use causes about one-third of cancer deaths in the nation overall, but the burden varies by state.

Pharmacies can offer an additional opportunity to aid individuals wanting to quit tobacco by providing immediate support and access to FDA-approved cessation medications.

Tobacco control partners provided comments on the Request for Information; Coverage of Over-the-Counter Preventative Services (CMS-9891-NC), including three nicotine replacement (NRT) products, which would increase access to effective tobacco cessation medications for adults who want to quit using commerncial tobacco products.

Tobacco use is one of the primary causes of cancer-related health disparities - disproportionately impacting people by race, ethnicity, sexual orientation, gender identity, disability status, mental health, income and education levels, and geographic location. Eliminating health disparities depends heavily on eliminating tobacco use. ACS CAN is pursuing evidence-based policies at the local, state, and federal levels that aim to reduce disparities and improve health outcomes for all individuals.

Big tobacco has a history of prioritizing corporate profits over people and communities burdened by tobacco-related illness and death. For decades, the tobacco industry has lied to specific communities and the public at large saying their products are not addictive, harmful or deadly. Tobacco manufacturers continue to create and flood the market with newly designed products they market as being less harmful and alternatives to quitting – a tactic that is not new.

While overall smoking rates have declined in recent years, smoking rates remain higher among specific populations, including people with limited incomes. These differences are in large part due to the tobacco industry’s targeted marketing through advertising, price discounting and other strategies. Every year the tobacco industry spends $9.1 billion in the United States marketing their deadly and addictive products. 

While overall smoking rates have declined in recent years, smoking rates remain higher among specific subpopulations, including African Americans. These differences are in large part due to the tobacco industry’s targeted marketing through advertising, price discounting and other strategies.

While overall smoking rates have declined in recent years, smoking rates remain higher among specific subpopulations, including the LGBTQ+ community. These differences are in large part due to the tobacco industry’s targeted marketing through advertising, price discounting and other strategies.